Antifibrotic actions of mycophenolic acid (Q36652027)

15 August 2017

1 reference

title

Antifibrotic actions of mycophenolic acid (English)

1 reference

15 August 2017

4

Arianeb Mehrabi

1 reference

15 August 2017

Christian Morath

1

1 reference

15 August 2017

Vedat Schwenger

2

1 reference

15 August 2017

Jörg Beimler

3

1 reference

15 August 2017

Jan Schmidt

5

1 reference

15 August 2017

Martin Zeier

6

1 reference

15 August 2017

Walter Muranyi

7

1 reference

15 August 2017

publication date

1 January 2006

1 reference

15 August 2017

published in

Clinical Transplantation

1 reference

15 August 2017

volume

20 Suppl 17

1 reference

15 August 2017

page(s)

25-29

1 reference

Mycophenolate mofetil and its mechanisms of action

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00597.X

Mycophenolic acid antagonizes the activation of cultured human mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00597.X

Mycophenolate mofetil inhibits rat and human mesangial cell proliferation by guanosine depletion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00597.X

Effects of mycophenolic acid on endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00597.X

Antiproliferative effect of mycophenolate mofetil on cultured human Tenon fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00597.X

Everolimus and mycophenolate mofetil are potent inhibitors of fibroblast proliferation after lung transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00597.X

Effects of commonly used immunosuppressants on graft-derived fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00597.X

Mycophenolate mofetil slows progression in anti-thy1-induced chronic renal fibrosis but is not additive to a high dose of enalapril

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00597.X

Cyclosporine withdrawal and mycophenolate mofetil treatment effects on the progression of chronic cyclosporine nephrotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00597.X

Synergistic effects of mycophenolate mofetil and losartan in a model of chronic cyclosporine nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00597.X

Mycophenolate mofetil ameliorates arteriolopathy and decreases transforming growth factor-beta1 in chronic cyclosporine nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00597.X

Mycophenolate mofetil treatment for primary glomerular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00597.X

Mycophenolate mofetil: implications for the treatment of glomerular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00597.X

Use of mycophenolate mofetil in steroid-dependent and -resistant nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00597.X

Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00597.X

Calcineurin-inhibitor related nephrotoxicity- reversibility in paediatric liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00597.X

Long-term impact of discontinued or reduced calcineurin inhibitor in patients with chronic allograft nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00597.X

Mycophenolate mofetil but not the type of calcineurin inhibitor (cyclosporine vs tacrolimus) influences the intragraft mRNA expression of cytokines in human kidney allograft biopsies by in situ RT-PCR analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00597.X

Mycophenolate mofetil-induced reversal of glomerular filtration loss in children with chronic allograft nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00597.X

Effect of cyclosporine, mycophenolic acid, and rapamycin on the proliferation of rat aortic vascular smooth muscle cells: in vitro study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00597.X

Mycophenolate mofetil (MMF, RS-61443) inhibits inflammation and smooth muscle cell proliferation in rat aortic allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00597.X

Effect of mycophenolate mofetil on the in vivo infiltration of lymphocytes in the rat remnant kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00597.X

Effect of the peritoneal dialysis prescription on pentosidine in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00597.X

Effects of mycophenolate mofetil and lisinopril on collagen deposition in unilateral ureteral obstruction in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00597.X

Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00597.X

Mycophenolate mofetil inhibits intimal hyperplasia and attenuates the expression of genes favouring smooth muscle cell proliferation and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00597.X

Mycophenolate mofetil prevents transplant arteriosclerosis by direct inhibition of vascular smooth muscle cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00597.X

A BLINDED, RANDOMIZED CLINICAL TRIAL OF MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN CADAVERIC RENAL TRANSPLANTATION1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2006.00597.X

10.1111/J.1399-0012.2006.00597.X

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference